Myelopoiesis during Solid Cancers and Strategies for Immunotherapy
Our understanding of the relationship between the immune system and cancers has undergone significant discovery recently. Immunotherapy with T cell therapies and checkpoint blockade has meaningfully changed the oncology landscape. While remarkable clinical advances in adaptive immunity are occurring...
Main Authors: | Tyler J. Wildes, Bayli DiVita Dean, Catherine T. Flores |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/968 |
Similar Items
-
Zebrafish: a convenient tool for myelopoiesis research
by: Yang-Xi Hu, et al.
Published: (2023-01-01) -
PU.1 is required to restrain myelopoiesis during chronic inflammatory stress
by: James S. Chavez, et al.
Published: (2023-06-01) -
Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis
by: Yaeko Nakajima-Takagi, et al.
Published: (2023-06-01) -
Ontogenic shifts in cellular fate are linked to proteotype changes in lineage-biased hematopoietic progenitor cells
by: Maria Jassinskaja, et al.
Published: (2021-03-01) -
Generation of Myeloid Cells in Cancer: The Spleen Matters
by: Chong Wu, et al.
Published: (2020-06-01)